Press Room

 

Apr

2016

29

Sept

2015

22

May

2015

Neurotech Announces Renewed Focus on NT-501 (CNTF) Encapsulated Cell Therapy Clinical Programs.

Click here for press release

 

 

 

 

Neurotech Announces First Patient Enrolled in Novel Anti VEGF Encapsulated Cell Therapy Study.

Click here for press release

 

 

 

 

Sustained Release Technology - EuroTimes, May 2015

Click here for article

Mar

2015

30

Mar

2015

18

Apr

2014

11

Neurotech Announces FDA Acceptance of Investigational New Drug Application and Clinical Trial Initiation of Novel Therapy for Wet AMD.

Click here for press release



 

Neurotech Announces Appointment of Dr. Charles Johnson as Chief Medical Officer.

Click here for press release

 

 

 

 

Quinton Oswald Appointed Chief Executive Officer of Neurotech Pharmaceuticals.

Click here for press release

Sept

2013

19

Aug

2013

6

Nov

2013

2

Sept

2012

28

Neurotech Pharmaceuticals Adds Ophthalmic Leaders to Advance Groundbreaking Sight-Saving Therapies.

Click here for press release

 

 

 

 

James Mazzo Appointed Executive Chairman of Neurotech Pharmaceuticals.

Click here for press release



 

Two-Year Intraocular Delivery of Ciliary Neurotrophic Factor by Encapsulated Cell Technology Implants in Patients with Chronic Retinal Degenerative Diseases by Kauper et al.

Click here for press release

 

 

 

Neurotech Pharmaceuticals relocates to 900 Highland Corporate Drive, Cumberland, Rhode Island

Sept

2012

18

July

2012

20

July

2012

24

June

2012

26

The FDA Orphan Product Division has awarded a grant ($1,459,330 – NIH R01 FD004100-01A1) to fund the study of NT-501 for RP using cone preservation as the endpoint (Jacque Duncan- University of Califo

 

 

 

 

Konrad Kauper to speak “Developing Sight-Saving Therapeutics for Chronic Retinal Diseases” at LCA Conference, Philadelphia, PA.

Go to LCA foundation

 

 

 

NT-501 granted orphan-drug designation for macular telangiectasia type 2 (MacTel).

Go to FDA orphan-drug site

 

 

 

 

Vincent Ling, Ph.D., to speak on Delivery of Alternative Scaffolds Using Encapsulated Cell Technology at IBC Next Generation Protein Summit 2012, San Francisco, CA

 

 

Neurotech © 2016

News Update

Find out the latest news at Neurotech